Upstream Bio (UPB) Equity Average (2023 - 2025)
Historic Equity Average for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $393.7 million.
- Upstream Bio's Equity Average rose 35652.68% to $393.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $393.7 million, marking a year-over-year increase of 35652.68%. This contributed to the annual value of $173.4 million for FY2024, which is N/A changed from last year.
- Upstream Bio's Equity Average amounted to $393.7 million in Q3 2025, which was up 35652.68% from $427.2 million recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Equity Average registered a high of $457.7 million during Q1 2025, and its lowest value of -$153.5 million during Q3 2024.
- Over the past 3 years, Upstream Bio's median Equity Average value was $18.6 million (recorded in 2023), while the average stood at $111.7 million.
- As far as peak fluctuations go, Upstream Bio's Equity Average skyrocketed by 23153.49% in 2024, and later soared by 45685.94% in 2025.
- Over the past 3 years, Upstream Bio's Equity Average (Quarter) stood at -$117.7 million in 2023, then surged by 231.53% to $154.8 million in 2024, then skyrocketed by 154.35% to $393.7 million in 2025.
- Its Equity Average stands at $393.7 million for Q3 2025, versus $427.2 million for Q2 2025 and $457.7 million for Q1 2025.